QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
City of Industry, CA -- (SBWIRE) -- 08/30/2018 -- This study focuses on the production side and consumption side of Blood Plasma Derivatives, presents the global Blood Plasma Derivatives market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
In terms of production side, this report researches the Blood Plasma Derivatives capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Blood Plasma Derivatives by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.
Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.
The Blood Plasma Derivatives market was valued at 24800 Million US$ in 2017 and is projected to reach 52000 Million US$ by 2025, at a CAGR of 9.7% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Blood Plasma Derivatives
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/691035/global-blood-plasma-derivatives-industry-research-report-growth-trends-and-competitive-analysis
.
This report includes the following manufacturers; we can also add the other companies as you want.
Grifols, S.A.
SK Plasma Co., Ltd.
Fusion Health Care Pvt. Ltd.
Biotest AG
Green Cross Corporation
Baxter International Inc.
LFB S.A.
Octapharma AG
CSL Limited
Shire Plc.
China Biologic Products, Inc.
Kedrion Biopharma, Inc.
BDI Pharma, Inc.
Bayer AG
Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/5810c886a3a960a7df37f5e3daf27165,0,1
Hualan Biological Engineering, Inc.
Market Segment by Product Type
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
Market Segment by Application
Hospitals
Clinics
Other End Users
Key Regions split in this report:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/691035/global-blood-plasma-derivatives-industry-research-report-growth-trends-and-competitive-analysis
About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.